Tiziana Life Sciences plc: Accustem Update

by NASDAQ Market News March 30, 2021

NASDAQ Market News
Click here to email author

Turkish Ministry of Health Approves Increase in Patient Recruitment into the Phase II Trial for LSALT Peptide

Intellia Therapeutics’ Investigational CRISPR Treatment NTLA-2001 Receives European Union Orphan Drug Designation for ATTR Amyloidosis

Ads